Wells Fargo & Company »

Neumora Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $466k 27k 17.05

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Artal Group
EcoR1 Capital
Avidity Partners Management
Citadel Advisors
Hillhouse Capital Advisors
OrbiMed Advisors
Goldman Sachs Group
Logos Global Management
Vanguard Group
Addis & Hill
Schonfeld Strategic Advisors
Pier Capital

View all funds holding Neumora Therapeutics